Literature DB >> 31088084

Synthesis of Sialyl LewisX Glycomimetics Bearing a Bicyclic 3- O,4- C-Fused Galactopyranoside Scaffold.

Ryan D Simard1,2, Mathieu Joyal3, Laura Gillard1, Gianna Di Censo1, Wael Maharsy3, Janie Beauregard3, Pina Colarusso4, Kamala D Patel4, Michel Prévost1, Mona Nemer3, Yvan Guindon1,2,3.   

Abstract

Reported herein is the synthesis of sialyl LewisX analogues bearing a trans-bicyclo[4.4.0] dioxadecane-modified 3- O,4- C-fused galactopyranoside scaffold that locks the carboxylate pharmacophore in either the axial or equatorial position. This novel series of bicyclic galactopyranosides are prepared through a stereocontrolled intramolecular cyclization reaction that has been evaluated both experimentally and by density functional theory calculations. The cyclization precursors are obtained from β-d-galactose pentaacetate in a nine-step sequence featuring a highly diastereoselective equatorial alkynylation and Cu(I) catalyzed formation of the acetylenic α-ketoester moiety. Preliminary biological evaluations indicate improved activity as P-selectin antagonists for the axially configured analogues as compared to their equatorial counterparts.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31088084     DOI: 10.1021/acs.joc.9b01075

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Multicomponent reaction derived small di- and tri-carbohydrate-based glycomimetics as tools for probing lectin specificity.

Authors:  Andreja Jakas; Ramya Ayyalasomayajula; Mare Cudic; Ivanka Jerić
Journal:  Glycoconj J       Date:  2022-08-24       Impact factor: 3.009

2.  A Sub-Micromolar MraYAA Inhibitor with an Aminoribosyl Uridine Structure and a (S,S)-Tartaric Diamide: Synthesis, Biological Evaluation and Molecular Modeling.

Authors:  Martin Oliver; Laurent Le Corre; Mélanie Poinsot; Michaël Bosco; Hongwei Wan; Ana Amoroso; Bernard Joris; Ahmed Bouhss; Sandrine Calvet-Vitale; Christine Gravier-Pelletier
Journal:  Molecules       Date:  2022-03-08       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.